These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 25425023)

  • 1. Effects of zoledronate on the radiation-induced collagen breakdown: a prospective randomized clinical trial.
    Gierloff M; Reutemann M; Gülses A; Niehoff P; Wiltfang J; Açil Y
    Clin Transl Oncol; 2015 Jun; 17(6):454-61. PubMed ID: 25425023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of zoledronate on irradiated bone in vivo: analysis of the collagen types I, V and their cross-links lysylpyridinoline, hydroxylysylpyridinoline and hydroxyproline.
    Açil Y; Gierloff M; Behrens C; Möller B; Gassling V; Niehoff P; Wiltfang J; Simon M
    Calcif Tissue Int; 2013 Mar; 92(3):251-60. PubMed ID: 23179106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II trial evaluating the palliative benefit of second-line zoledronic acid in breast cancer patients with either a skeletal-related event or progressive bone metastases despite first-line bisphosphonate therapy.
    Clemons MJ; Dranitsaris G; Ooi WS; Yogendran G; Sukovic T; Wong BY; Verma S; Pritchard KI; Trudeau M; Cole DE
    J Clin Oncol; 2006 Oct; 24(30):4895-900. PubMed ID: 17001071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measurement of urinary excretion of nonisomerized and beta-isomerized forms of type I collagen breakdown products to monitor the effects of the bisphosphonate zoledronate in Paget's disease.
    Garnero P; Gineyts E; Schaffer AV; Seaman J; Delmas PD
    Arthritis Rheum; 1998 Feb; 41(2):354-60. PubMed ID: 9485094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiotherapy to bone metastases from renal cell carcinoma with or without zoledronate.
    Kijima T; Fujii Y; Suyama T; Okubo Y; Yamamoto S; Masuda H; Yonese J; Fukui I
    BJU Int; 2009 Mar; 103(5):620-4. PubMed ID: 18990143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zoledronic acid in the treatment of bone metastases from differentiated thyroid carcinoma.
    Orita Y; Sugitani I; Toda K; Manabe J; Fujimoto Y
    Thyroid; 2011 Jan; 21(1):31-5. PubMed ID: 21058881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized trial comparing efficacies of zoledronate and alendronate for improving bone mineral density and inhibiting bone remodelling in women with post-menopausal osteoporosis.
    Tan W; Sun J; Zhou L; Li Y; Wu X
    J Clin Pharm Ther; 2016 Oct; 41(5):519-23. PubMed ID: 27440710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positive effects of zoledronate on skeletal-related events in patients with renal cell cancer and bone metastases.
    Tunn UW; Stenzl A; Schultze-Seemann W; Strauss A; Kindler M; Miller K; Wirth MP; Zantl N; Schulze M; May C; Ruebel A; Birkholz K; Gruenwald V
    Can J Urol; 2012 Jun; 19(3):6261-7. PubMed ID: 22704310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zoledronic acid and survival in breast cancer patients with bone metastases and elevated markers of osteoclast activity.
    Lipton A; Cook RJ; Major P; Smith MR; Coleman RE
    Oncologist; 2007 Sep; 12(9):1035-43. PubMed ID: 17914073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zoledronic acid: past, present and future roles in cancer treatment.
    Saad F
    Future Oncol; 2005 Apr; 1(2):149-59. PubMed ID: 16555985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical analysis of therapeutic effect of zoledronic acid combined with radiotherapy for metastatic bone cancer].
    Cheng J; Xue J; Wu HG; Wu G
    Zhonghua Zhong Liu Za Zhi; 2008 Jul; 30(7):552-4. PubMed ID: 19062728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Additive effect of zoledronic acid on serum prostate-specific antigen changes for hormone-sensitive prostate cancer patients with bone metastasis treated by combined androgen blockade.
    Kamiya N; Suzuki H; Endo T; Takano M; Yano M; Naoi M; Nishimi D; Kawamura K; Imamoto T; Ichikawa T
    Int J Urol; 2012 Feb; 19(2):169-73. PubMed ID: 22126137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of bisphosphonates in the treatment of prostate cancer: recommendations from an expert panel.
    Saad F; Higano CS; Sartor O; Colombel M; Murray R; Mason MD; Tubaro A; Schulman C
    Clin Genitourin Cancer; 2006 Mar; 4(4):257-62. PubMed ID: 16729908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zoledronic acid enhances the effect of radiotherapy for bone metastases from renal cell carcinomas: more than a 24-month median follow-up.
    Takeda N; Isu K; Hiraga H; Shinohara N; Minami A; Kamata H
    J Orthop Sci; 2012 Nov; 17(6):770-4. PubMed ID: 23053582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validity of bone marker measurements for monitoring response to bisphosphonate therapy with zoledronic acid in metastatic breast cancer.
    Aktas B; Kasimir-Bauer S; Lehmann N; Kimmig R; Tewes M
    Oncol Rep; 2013 Jul; 30(1):441-7. PubMed ID: 23604361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antitumor properties of the bisphosphonate zoledronate and potential therapeutic implications in the clinic].
    Clézardin P
    Bull Cancer; 2010 Aug; 97(8):937-49. PubMed ID: 20595092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes of bone resorption marker (NTX) in chemotherapy plus zoledronic acid versus chemotherapy alone for nasopharyngeal cancer patients with bone metastases.
    Zhao YY; Xue C; Hou X; Liao H; Li S; Zhao HY; Huang Y; Chen LK; Xu F; Liu JL; Zhang L
    Eur J Cancer; 2011 Apr; 47(6):848-53. PubMed ID: 21256000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zoledronic acid treatment for cancerous bone metastases: a phase IV study in Taiwan.
    Chiang PH; Wang HC; Lai YL; Chen SC; Yen-Hwa W; Kok CK; Ou YC; Huang JS; Huang TC; Chao TY
    J Cancer Res Ther; 2013; 9(4):653-9. PubMed ID: 24518712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zoledronic acid in lung cancer with bone metastases: a review.
    Isla D; Afonso R; Bosch-Barrera J; Martínez N
    Expert Rev Anticancer Ther; 2013 Apr; 13(4):421-6. PubMed ID: 23560837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical value of bone remodelling markers in patients with bone metastases treated with zoledronic acid.
    Pectasides D; Nikolaou M; Farmakis D; Kanakis I; Gaglia A; Kountourakis P; Karamanos NK; Economopoulos T; Raptis SA
    Anticancer Res; 2005; 25(2B):1457-63. PubMed ID: 15865105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.